CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 
 

ORMP's Revenue Growth by Quarter and Year

Oramed Pharmaceuticals Inc 's Revenue results by quarter and year




ORMP Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter August - 0.68 0.62 4.29
III Quarter May 0.68 0.68 0.62 -0.62
II Quarter February 0.67 0.67 0.60 -0.61
I Quarter November 0.67 0.67 0.61 -0.61
FY   2.02 2.70 2.45 2.45



ORMP Revenue third quarter 2020 Y/Y Growth Comment
Oramed Pharmaceuticals Inc reported Revenue growth of 0.15% year on year in the third quarter, to $ 0.68 millions, this is lower than Oramed Pharmaceuticals Inc 's recent average Revenue growth of 5.29%.

According to the results reported in the third quarter, Oramed Pharmaceuticals Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Oramed Pharmaceuticals Inc ' s Revenue increase of 0.15% ranks overall at the positon no. 27 in the third quarter.




ORMP Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter August - 9.68 % -85.55 % -
III Quarter May 0.15 % 9.68 % - -
II Quarter February 0 % 11.67 % - -
I Quarter November 0 % 9.84 % - -
FY   - 10.2 % -0 % -

Financial Statements
Oramed Pharmaceuticals Inc 's third quarter 2020 Revenue $ 0.68 millions ORMP's Income Statement
Oramed Pharmaceuticals Inc 's third quarter 2019 Revenue $ 0.68 millions Quarterly ORMP's Income Statement
New: More ORMP's historic Revenue Growth >>


ORMP Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter August - 0 % 0 % -
III Quarter May 1.64 % 1.49 % 3.33 % -
II Quarter February 0 % 0 % -1.64 % -
I Quarter November -1.47 % 8.06 % -85.78 % -
FY (Year on Year)   - 10.2 % -0 % -




Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #4
Overall #27

Revenue Y/Y Growth Statistics
High Average Low
49.71 % 5.29 % -60.02 %
(Nov 30 2017)   (Aug 31 2018)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #4
Overall #27
Revenue Y/Y Growth Statistics
High Average Low
49.71 % 5.29 % -60.02 %
(Nov 30 2017)   (Aug 31 2018)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Oramed Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
30.4 % -3.67 % -85.77 %
(May 31 2016)  


ORMP's III. Quarter Q/Q Revenue Comment
Oramed Pharmaceuticals Inc achieved in the III. Quarter 2020 above company average sequential Revenue growth of 1.64%, to $ 0.68 millions, from $0.67 millions in the second quarter.
Oramed Pharmaceuticals Inc is impressively improving, with recording above average increase, but also increasing rate.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest sequential Revenue growth. While Oramed Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 30.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #30
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #30
Revenue Q/Q Growth Statistics
High Average Low
30.4 % -3.67 % -85.77 %
(May 31 2016)  


ORMP's III. Quarter Q/Q Revenue Comment
Oramed Pharmaceuticals Inc achieved in the III. Quarter 2020 above company average sequential Revenue growth of 1.64%, to $ 0.68 millions, from $0.67 millions in the second quarter.
ORMP is impressively improving, not only recording better then average increase, but also accelerating speed, Sean U. King, a business advisor said.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest sequential Revenue growth. While Oramed Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 30.


Oramed Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2020)
12 Months Ending
(Feb 29 2020)
12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
Cumulative Revenue 12 Months Ending $ 2.71 $ 2.71 $ 2.70 $ 2.70 $ 2.64
Y / Y Revenue Growth (TTM) 2.69 % 5.32 % 7.6 % 10.37 % -56.92 %
Year on Year Revenue Growth Overall Ranking # 37 # 20 # 372 # 988 # 45
Seqeuential Revenue Change (TTM) -0.04 % 0.3 % 0 % 2.43 % 2.53 %
Seq. Revenue Growth (TTM) Overall Ranking # 27 # 20 # 608 # 1067 # 35




Cumulative Revenue growth Comment
Assuming the Oramed Pharmaceuticals Inc 's fiscal year would have ended in May 31 2020, Oramed Pharmaceuticals Inc would have reprted above average annual Revenue improvement of 2.69% year on year, of $ 3 millions.
This marks a slow-down of the companys growth trends and from the 5.32% growth in Feb 29 2020. But still, Oramed Pharmaceuticals Inc had highest Revenue growth, in Major Pharmaceutical Preparations industry.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 20 to 37.

Revenue TTM Q/Q Growth Statistics
High Average Low
49.71 %
5.29 %
-60.02 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 3
Overall # 37

Revenue TTM Y/Y Growth Statistics
High Average Low
10.37 %
-13.79 %
-56.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 4
S&P 500 # 27
Cumulative Revenue growth Comment
Assuming the Oramed Pharmaceuticals Inc 's fiscal year would have ended in May 31 2020, Oramed Pharmaceuticals Inc would have reprted above average annual Revenue improvement of 2.69% year on year, of $ 3 millions.
This marks a slow-down of the companys growth trends and from the 5.32% growth in Feb 29 2020. But still, Oramed Pharmaceuticals Inc had highest Revenue growth, in Major Pharmaceutical Preparations industry.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 20 to 37.

Revenue TTM Q/Q Growth Statistics
High Average Low
49.71 %
5.29 %
-60.02 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 3
Overall # 37

Revenue TTM Y/Y Growth Statistics
High Average Low
10.37 %
-13.79 %
-56.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 4
S&P 500 # 27




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ORMP's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ORMP's Competitors
Revenue Growth for Oramed Pharmaceuticals Inc 's Suppliers
Revenue Growth for ORMP's Customers

You may also want to know
ORMP's Annual Growth Rates ORMP's Profitability Ratios ORMP's Asset Turnover Ratio ORMP's Dividend Growth
ORMP's Roe ORMP's Valuation Ratios ORMP's Financial Strength Ratios ORMP's Dividend Payout Ratio
ORMP's Roa ORMP's Inventory Turnover Ratio ORMP's Growth Rates ORMP's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending May 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2020
Walgreens Boots Alliance Inc   0.12 %$ 0.116 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EXPCU's Profile

Stock Price

EXPCU's Financials

Business Description

Fundamentals

Charts & Quotes

EXPCU's News

Suppliers

EXPCU's Competitors

Customers & Markets

Economic Indicators

EXPCU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071